Loading organizations...
MyC MedTech has raised $13.8M across 2 funding rounds.
Key people at MyC MedTech.
MyC MedTech has raised $13.8M in total across 2 funding rounds.
MyC provides an enterprise health platform optimizing health management for large organizations. This clinical-grade cloud solution integrates medical data, streamlining multi-site operations, ensuring compliance, and delivering predictive insights for workforce health. It employs secure communications and certified cloud infrastructure for robust strategy management.
Co-built with OSS Ventures, MyC emerged from Laurent, a surgeon from extreme environments, including Médecins Sans Frontières. Laurent, alongside Benjamin, identified a critical software gap for health professionals outside traditional clinics. This insight, highlighted by fragmented data and operational inefficiencies during pandemic responses, catalyzed MyC's inception.
MyC primarily serves multinational enterprises and medical service providers with distributed workforces. Its vision transforms organizational employee well-being from reactive incident management to proactive health strategies. The company empowers professionals with integrated tools, enhancing compliance, reducing absenteeism, and driving operational excellence.
MyC MedTech has raised $13.8M across 2 funding rounds. Most recently, it raised $11.8M MyC - Series A in February 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 3, 2026 | $11.8M Series A | HI Inov Dentressangle | Elaia, IXO Private Equity, OSS Ventures | Announced |
| Jun 1, 2021 | $2M Seed | — | Elaia Partners | Announced |
MyC MedTech has raised $13.8M in total across 2 funding rounds.
MyC MedTech's investors include Hi Inov - Dentressangle, Elaia, IXO Private Equity, OSS Ventures, Elaia Partners.
Key people at MyC MedTech.
MyC MedTech is a French healthtech company developing a cloud-based software platform that serves as an operating system for company medical services, enabling secure management of employee health data, medical check-ups, and remote medical sites worldwide.[1][2][3] It targets corporations in high-risk sectors like energy, manufacturing, construction, hospitality, and offshore operations across Europe, Africa, and Asia, solving the problem of fragmented health data by providing predictive analytics to spot trends, prevent outbreaks, reduce injuries, contain costs, and improve productivity through proactive health risk management.[1][2][3] The platform features intuitive electronic health records (EHR), real-time dashboards, ISO 27001, GDPR, and HIPAA compliance, with early traction from numerous clients and a €2m seed round in 2021 led by Elaia Partners.[1][2]
MyC MedTech was co-founded by Benjamin Crevant (CEO) and Laurent (likely Laurent de la Clergerie, linked to OSS Ventures in smart factory tech), two entrepreneurs with international track records in manufacturing and tech transformation.[1] The idea emerged to help companies enter "health prevention 2.0" by scaling secure health data management for employees, addressing needs like monitoring flu outbreaks, BMI deterioration, and chronic diseases such as diabetes or high blood pressure.[1] Early traction included adoption by medical service providers and corporates in energy, manufacturing, construction, and hospitality across multiple continents, with plans for a first foreign office by 2022; the €2m seed funding in 2021 from Elaia Partners and business angels validated their fast execution.[1]
MyC rides the wave of health prevention 2.0 and digital health transformation, where companies increasingly prioritize employee wellness data to cut costs, enhance safety, and comply with regulations amid rising chronic diseases and remote work challenges.[1][2] Timing aligns with post-pandemic emphasis on predictive health analytics and AI-driven risk management, fueled by market forces like GDPR/HIPAA demands, offshore/high-risk industry needs, and the shift to cloud-based EHRs.[1][2][4] It influences the ecosystem by empowering corporates to act as health prevention leaders, potentially setting standards for data-driven occupational health in Europe and beyond, with early investor backing signaling scalability.[1]
MyC is poised to expand globally, building on its 2021 seed momentum toward leadership in corporate health platforms, likely pursuing further funding for AI enhancements and new markets like the US.[1][2] Trends in predictive health AI, regulatory compliance, and workforce safety in energy/offshore sectors will propel growth, evolving its role from data manager to full proactive wellness orchestrator. As corporates demand scalable prevention tools, MyC's secure, analytics-powered edge positions it to transform employee health at scale, echoing its founding vision of healthier, more productive workforces.[1][2]
